Stock Market MBX Biosciences director buys $10 million in IPO sharesSeptember 21, 20240 In a recent market development, Patrick J. Heron, a director and significant shareholder at MBX Biosciences, Inc. (NASDAQ:MBX), demonstrated strong…
Stock Market MBX Biosciences director buys $12 million in company stockSeptember 20, 20240 MBX Biosciences, Inc.’s director, Aynechi Tiba, recently made a significant investment in the company by acquiring 750,000 shares of common…
Stock Market MBX Biosciences director buys $12m in company stockSeptember 20, 20240 In a recent show of confidence in MBX Biosciences, Inc. (NYSE:MBX), Director Carl L. Gordon has made a significant purchase…
Stock Market Cellectar Biosciences reports strong trial results for iopofosineAugust 25, 20240 Cellectar Biosciences (NASDAQ:) shared positive updates during its recent earnings call, highlighting the successful trial results of its lead drug…
